The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced Myelosupression
Sponsored by Taipei Medical University
About this trial
Last updated 9 years ago
Study ID
TMU-JIRB: 201501030
Status
Unknown status
Type
Interventional
Phase
N/A
Placebo
No
Accepting
20 to 70 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Ended 7 years ago
What is this trial about?
In this proposed project, the investigator will estimate the effect of massotherapy of
acupoints on alleviating chemotherapy-induced myelosuppression among patients with
cancer.
What are the participation requirements?
Inclusion Criteria
- newly diagnosed of gynecologic cancer, regardless of stage.
- receiving initial chemotherapy.
- ability to write informed consent.
- between 20 to 70 years old.
Exclusion Criteria
- history of severe cardiac disorder.
- suffering from the hematological diseases such as hemolytic anemia.
- cancer patients with lymphoedema at the area of the acupressure points.
- diagnosed combine with other cancers.
Locations
Location
Status
Recruiting